These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8189086)

  • 21. Polychromatic corneal and conjunctival crystals secondary to clofazimine therapy in a leper.
    Font RL; Sobol W; Matoba A
    Ophthalmology; 1989 Mar; 96(3):311-5. PubMed ID: 2710521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind controlled clinical trial to assess the role of anti-histamines in the treatment of multi-bacillary leprosy.
    Thomas A; Nagarajan M; Chandrasekaran V; Hari L; Somasundaram PR; Prabhakar R; Kumar A; Bhatia VN; Roy RG
    Indian J Lepr; 1988 Oct; 60(4):499-505. PubMed ID: 3075630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lepromatous leprosy with drug reaction.
    Baxt RD
    Dermatol Online J; 2000 Sep; 6(1):9. PubMed ID: 11328619
    [No Abstract]   [Full Text] [Related]  

  • 25. Resolution of lepromatous leprosy after a short course of amoxicillin/clavulanic acid, followed by ofloxacin and clofazimine.
    Villahermosa LG; Walsh DS; Fajardo TT; Abalos RM; dela Cruz EC; Veerasubramanian P; Walsh GP
    Int J Dermatol; 1999 Jul; 38(7):558-60. PubMed ID: 10440294
    [No Abstract]   [Full Text] [Related]  

  • 26. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of clofazimine on eye in multibacillary leprosy.
    Kaur I; Ram J; Kumar B; Kaur S; Sharma VK
    Indian J Lepr; 1990; 62(1):87-90. PubMed ID: 2358706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and bacteriological relapse after MDT in a lepromatous patient: a case report.
    Shanker PV
    Indian J Lepr; 1991; 63(2):229-31. PubMed ID: 1783792
    [No Abstract]   [Full Text] [Related]  

  • 29. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 31. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is your diagnosis? Lepromatous leprosy.
    Kline L; Powers R; Defazio J
    Cutis; 2015 Jan; 95(1):19, 25-6. PubMed ID: 25671446
    [No Abstract]   [Full Text] [Related]  

  • 33. Limitations of clofazimine in the treatment of lepra reactions.
    Mishra B; Girdhar BK
    Indian J Lepr; 1986; 58(1):73-8. PubMed ID: 3746000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
    Ekambaram V; Rao MK
    Indian J Lepr; 1989 Jan; 61(1):31-43. PubMed ID: 2784822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
    Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966-1978.
    Browne SG; Harman DJ; Waudby H; McDougall AC
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):167-76. PubMed ID: 7196886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autopsy findings in a case of lepromatous leprosy treated with clofazimine.
    Desikan KV; Ramanujam K; Ramu G; Balakrishnan S
    Lepr Rev; 1975 Sep; 46(3):181-9. PubMed ID: 1186410
    [No Abstract]   [Full Text] [Related]  

  • 38. Bullous pemphigoid in lepromatous leprosy.
    Thappa DM; Rao MV; Garg BR; Ratnakar C
    Indian J Lepr; 1996; 68(3):251-4. PubMed ID: 8889611
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of histoid leprosy responding to ofloxacin along with standard MDT.
    Vora NS; Vora VN; Mukhopadhyay AK; Roy K; Patel NN; Ghosh A
    Indian J Lepr; 1995; 67(2):183-6. PubMed ID: 8537707
    [No Abstract]   [Full Text] [Related]  

  • 40. Side effects of clofazimine therapy.
    Ramu G; Iyer GG
    Lepr India; 1976 Oct; 48(4 Suppl):722-31. PubMed ID: 1026810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.